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Introduction
============

Brain tissue is particularly vulnerable to ischemia due to the high dependence of the oxidative phosphorylation for ATP synthesis and limited energy reserves. Ischemia results in subtle time-dependent ionic changes in intracellular and extracellular spaces that lead to redistribution of brain water pools, release of excitotoxic neurotransmitters and ultimately initiation of destructive processes [@B0]. In focal ischemia, tissue damage spreads beyond the initial core if blood flow is not restored within a certain time frame [@B1]. The time of stroke onset is currently one of the key criteria in clinical decisions for the pharmacotherapy of ischemic stroke, including recanalization by thrombolytic agents [@B2]. Consequently, many patients are automatically ineligible for thrombolytic therapy due to unknown symptom onset time, owing to the stroke occurring during sleep (\'wake-up stroke\'), lack of witness, or being unaware of symptoms [@B3][@B4]. A procedure that determines the time of stroke onset is therefore required so that such patients may be considered for thrombolysis.

MRI probes water *in vivo*. Dynamics of which are severely perturbed by acute ischemic energy failure [@B5]. Most notably, the diffusion of water governed by translational (thermal) motion of water molecules is reduced in the early moments of ischemia due to the energy failure [@B6]. This in turn results in anoxic depolarization of neural cells [@B7]. Diffusion MRI (DWI) has become a gold standard diagnostic imaging modality for acute stroke [@B8]. The DWI signal increases rapidly in response to ischemia allowing ischemic tissue to be identified but does not show any time-dependency during the first few hours of ischemic stroke [@B9]. Likewise, quantitative measures of water diffusion such as the apparent diffusion coefficient (ADC) or the trace of the diffusion tensor (D~av~) decrease rapidly in ischemic tissue, but show no relationship with time from stroke onset in animal stroke models [@B9] and patients [@B10].

Quantitative MRI (qMRI) relaxation parameters, qT~1~, qT~2~ and qT~1ρ~, are governed by rotational motion and the exchange of water hydrogen atoms and show complex time-dependent changes in brain parenchyma following ischemic energy failure [@B5]. Such time-dependent changes enabled stroke onset time to be estimated in patients [@B11] and animal models of ischemia [@B12][@B13][@B14]. In rat focal stroke, qT~1ρ~increases almost instantaneously after ischemia onset and continues linearly for at least 6 hours [@B12][@B13]. qT~1~ relaxation times also increase in a time-dependent fashion in ischemic brain tissue which can be described by two time constants: an initial fast phase followed by a slow phase lasting for hours [@B7][@B15]. Because of this biphasic increase, the use of qT~1~ in stroke timing may be more complicated than that of qT~1ρ~ MRI [@B14]. qT~2~ relaxation times also show a bi-phasic change in rat focal stroke, whereby there is an initial shortening within the first hour, followed by a linear increase with time [@B12]. The initial shortening can be explained by two parallel running factors including: (i) the buildup of deoxyhemoglobin resulting in the so-called \'negative blood oxygenation level dependent effect\' and (ii), the shift of extracellular water into the intracellular space [@B16][@B17]. The time-dependent increase in qT~2~ is likely due to cytotoxic and/or vasogenic edema with subsequent breakdown of intracellular macromolecular structures [@B17]. Both qT~1ρ~ and qT~2~ data provide accurate estimates of stroke onset time in preclinical models [@B13]. qT~2~ [@B11] and T~2~-weighted signal intensities [@B18][@B19] have also been exploited for stroke onset time estimation in clinical settings.

In addition to hemispheric differences in quantitative relaxation times, the spatial distribution of elevated relaxation times within the ischemic region may also serve as surrogates for stroke onset time [@B13]. In rat models of stroke, regions with elevated qT~1ρ~, qT~2~ and qT~1~ relaxation times are initially smaller than the diffusion defined ischemic lesion but increase with time [@B13][@B14][@B20]. Hence quantification of the spatial distribution of elevated relaxation times as a percentage of the size of the ischemic lesion also enables stroke onset time to be estimated [@B13][@B14]. Here, we describe the protocol to determine stroke onset time in a rat model of stroke using qMRI parameters.

Protocol
========

Animal procedures were conducted according to European Community Council Directives 86/609/EEC guidelines and approved by the Animal Care and Use Committee of the University of Eastern Finland, Kuopio, Finland.

1. Animal Model
---------------

1.  **Anesthetize male Wistar rats weighing 300 - 400 g with isoflurane in N~2~/O~2~ flow (70%/30%) through a facemask for the duration of the operation and MRI experiments. Induce anesthesia in ventilated hood. Maintain isoflurane levels between 1.5 and 2.4%.** Monitor depth of anesthesia during MRI from breathing frequency via a pneumatic pillow under the torso. Lack of response to pinch reflex is taken as a sign of sufficient depth for surgical anesthesia. Use isoflurane scavenger attached to a magnet bore.

2.  **Perform permanent middle cerebral artery occlusion (MCAO) to induce focal ischemic stroke. Use the intraluminal thread model for MCAO and carry out the operation according to methods given by Longa*et al.*[@B21].** Leave the occluding thread (silicon-PTFE tempered monofil filament, diameter 0.22 mm) in place for the duration of the MRI experiment.

3.  **Analyze arterial blood gases and pH using a blood analyzer.** During the MRI, monitor the breathing rate with a pneumatic pillow placed under the torso and the rectal temperature using a rectal temperature monitoring system. Maintain a core temperature close to 37 °C using a water heating pad under the torso.Immediately after MCAO, secure the rat in a cradle at the center of the magnet bore using a rat head holder. Inject 2 mL of saline intraperitoneally before transferring the rats into the magnet bore.

2. MRI
------

1.  Acquire MRI data using a 9.4T/31 cm (with the 12-cm gradient insert) horizontal magnet interfaced to a console equipped with an actively decoupled linear volume transmitter and quadrature receiver coil pair.

2.  **Scan each rat for up to 5 h post MCAO. At hourly intervals (60, 120, 180, 240 min post MCAO), acquire 12 congruently sampled (0.5 mm slice-gap, slice thickness = 1 mm, field of view = 2.56 cm x 2.56 cm) coronal slices of the trace of diffusion tensor (2.2.1.), Carr-Purcell-Meiboom-Gill T~2~(2.2.2.) and Fast Low Angle Shot T~1~ (2.2.3.).** Obtain the trace of the diffusion tensor images (D~av~= 1/3 trace \[D\]) with three bipolar gradients along each axis (the duration of the diffusion gradient = 5 ms, the diffusion time = 15 ms) and three b-values (0, 400 and 1400 s/mm-^2^s), where, Δ = 15 ms, ∂ = 5 ms, echo time (TE) = 36 ms, repetition time (TR) = 4000 ms and acquisition time = 7.36 min.Obtain the Carr-Purcell-Meiboom-Gill T~2~sequence with 12 echoes for T~2~ quantification, where echo-spacing = 10 ms, TR = 2000 ms and acquisition time = 4.20 min.Obtain the Fast Low Angle Shot (FLASH) for T~1~, where the time from inversion to the first FLASH sequence (T~10~) is 7.58 ms, with 600 ms increments of 10 inversions up to 5407.58 ms, TR = 5.5 ms, time between inversion pulses (T~relax~) = 10 s and acquisition time = 8.20 min.

3. Image Processing
-------------------

1.  **Computation of relaxometry and ADC maps: Compute qT~2~, qT~1~ and ADC maps using Matlab functions provided on University of Bristol website \[DOI:10.5523/bris.1bjytiabmtwqx2kodgbzkwso0k\], for which the input is a file path to the location of the MRI data.** For T~2~ data, apply Hamming filtering in k-space prior to reconstruction of images (or in image domain by convolution, with equivalent results but computationally less efficient). Compute qT~2~ maps by taking the logarithm of each time series and solving on a voxel-wise basis by linear least-squares (a bi-exponential fit can also be performed to the T~2~ decays, but the voxel-wise F-tests tests revealed that voxels within the image for which additional parameters could not be justified).For T~1~ data, apply Hamming filtering in k-space prior to reconstruction of images. Perform T~1~ fitting according to methods given in reference [@B22]. To deal with the problem of unknown sign (due to the use of magnitude images), the lowest-intensity point may be either excluded, or estimated in the course of fitting with similar results.For diffusion-weighted data, apply Hamming filtering by convolution in image domain (this is more straightforward due to the segmented k-space trajectory). Fit ADC maps by the method in[@B12].

2.  **Identification of ischemic tissue** Identify ischemic tissue on reciprocal D~av~ images (1/D~av~) as this provides clear contrast for lesion identification. To generate ischemic volumes of interest (VOI), define ischemic tissue as voxels with values one median absolute deviation above the median value of the whole-brain 1/D~av~ distribution. To identify homologous regions in the non-ischemic hemisphere, reflect the ischemic VOI about the vertical axis. Manually adjust non-ischemic VOIs to avoid including voxels containing cerebrospinal fluid.In order to determine the relationship of qT~1~ and qT~2~ with time post MCAO, for each rat and time-point, load the ischemic and non-ischemic VOIs onto qT~1~ and qT~2~ maps. Extract mean relaxation times and calculate the percentage difference in qT~1~ and qT~2~ between hemispheres (ΔT~1~ and ΔT~2~) using the following equation: Where T~x~ is the chosen parameter, qT~1~ or qT~2~. refers to the mean relaxation time of the ischemic VOI and the mean relaxation time in the non-ischemic VOI. The non-ischemic VOI should be used so that each rat serves as its own control.Use the following criteria to identify voxels with elevated qT~1~ and qT~2~: any voxels within the ischemic VOI with relaxation times exceeding the median relaxation time of the qT~1~ or qT~2~ distribution in the non-ischemic VOI by more than one half-width at half-maximum (HWMH). These criteria mean relaxation times must be in the 95^th^ percentile or higher to be classified as \'high\'. Use of the median relaxation time of the non-ischemic VOI allows each rat to serve as its own control.To picture the spatial distribution of relaxation time changes within regions of decreased diffusion, identify and color code voxels with elevated qT~1~ or qT~2~as well as voxels with both elevated qT~1~ and qT~2~ termed \'qT~1~and qT~2~ overlap\'.To determine the size of the lesion according to qT~1~ and qT~2~, compute the parameter f (as introduced by Knight *et al.* [@B17]) from MRI data acquired for each rat and time-point. f~1~ and f~2~ represent the number of voxels with high qT~1~ or qT~2~ (respectively) as a percentage of the size of the ischemic VOI. Use the following equation to calculate f~1~ and f~2~: Where refers to the relaxation time (qT~1~ or qT~2~), refers to the number of \'high\' relaxation time voxels in the ischemic VOI, is the number of \'low\' relaxation time voxels in the ischemic VOI and , the total number of voxels within the ischemic VOI. Criteria for identifying voxels with elevated qT~1~ and qT~2~ are outlined in section 3.2.3. \'Low\' voxels are voxels with relaxation times less than the median qT~1~ or qT~2~of the non-ischemic VOI by one HWHM. The subtraction of allows for decreases in relaxation times due to ischemia or other pathologies [@B16]. Determine the extent of \'qT~1~ and qT~2~ overlap\' by calculating the volume of overlapping elevated qT~1~ and qT~2~ as a percentage of whole brain volumes, hereby referred to as \'V^Overlap^\'. Use the following equation: Where, refers to the number of voxels within the ischemic VOI with both \'high\' qT~1~ and \'high\' qT~2~and represents the total number of voxels in the whole rat brain. Determine the number of voxels in the rat brain by manually creating a VOI around the whole brain on qT~2~relaxometry maps.

4. Verification of Ischemic Lesion with Triphenyletrazolium Chloride (TTC)
--------------------------------------------------------------------------

1.  Immediately after decapitation, carefully extract the rat brain from the skull. Complete this procedure within 10 min from the time the rat was decapitated.

2.  Store brains in refrigerated 0.01 M phosphate buffered saline (PBS) before using a rat brain slicer matrix to section the brain into serial 1 mm-thick coronal slices.

3.  **After sectioning, incubate each brain slice in 20 mL PBS containing TTC at 37 °C for 30 min in the dark, as recommended in [@B23]. Although 1% TTC concentration is acceptable, use 0.5% for improved contrast.** Cover the containers of the sections in foil to keep it dark.

4.  After incubation, remove the TTC solution using a pipette and wash slices in three changes of PBS.

5.  Immediately photograph slices using a standard light microscope and a digital camera.

5. Statistical Analysis
-----------------------

1.  Carry out statistical analysis using Matlab and statistical software.

2.  **Determining the relationship of MR parameters with time** Perform Pearson\'s correlations on pooled rat data to determine the relationship of ΔT~1~, ΔT~2,~ f~1~ and f~2~and*V*^Overlap^with time post MCAO.For parameters that show a significant linear relationship (*p* \<0.05), perform linear least square regression to determine whether stroke onset time can be predicted by quantifying the parameter of interest. Use the root mean square error (RMSE) to assess the accuracy of onset time estimates.

3.  **Quantification of lesion size** To compare lesion sizes according to different qMRI parameters, conduct one-way related ANOVAs and Fisher\'s least significant difference post-hoc on the average number of voxels in the ischemic VOI and the average number of voxels with high qT~1~ and qT~2~. Differences are considered significant at *p* \<0.05. If sphericity assumptions are not met per Mauchly\'s sphericity test, correct degrees of freedom and significance values according to Greenhouse Geisser estimates.

Representative Results
======================

Across rats the blood gas profiles were as follows: SO~2~ 95.8 ± 3.2%, P~a~CO~2~ 51.6 ± 2.9 mmHg, and pH 7.30 ± 0.04.

Typical D~av~, qT~2~ and qT~1~ images from a central slice of a representative rat at 4 time points post MCAO are shown in the first 3 panels of [Figure 1a](#F1){ref-type="fig"}. Images in the other panels of [Figure 1](#F1){ref-type="fig"} show the automatically detected ischemic lesion in red and regions within the ischemic lesion with elevated qT~1~, qT~2~ and regions with V^overlap^ are shown in green. Up to 2 h post-MCAO, regions with high qT~1~ within the ischemic lesion were significantly larger than high qT~2~(*p* \<0.01), but converged with time ([Figure 1](#F1){ref-type="fig"}). The ischemic lesion by D~av~ was also larger than regions of high qT~1~ (*p* \<0.05) and qT~2~ (*p* \<0.05) in the first two hours.

The time dependencies of qMRI parameters are shown in [Figure 2](#F2){ref-type="fig"}. All qMRI parameters were significant predictors of time post MCAO (ΔT1: *R*^2^ = 0.71, ΔT~2~:* R*^2^ = 0.75, f~1~: *R*^2^ = 0.53, f~2~: *R*^2^ = 0.82, V^overlap^: *R*^2^ = 0.87). Based on the RMSE for each parameter, uncertainties associated with estimates of time since stroke onset were ± 37 min for ΔT~1~, ± 28 min for ΔT~2~, ± 47 min for f~1~, ±34 min for f~2~, and ±25 min for V^overlap^. Thus, V^overlap^ gave the most accurate estimate of time since stroke onset.

TTC staining of brains samples around 6 h after MCAO verified irreversible ischemic damage predominantly in grey matter ([Figure 1d](#F1){ref-type="fig"}).

**Figure 1: Changes in qMRI parameters due to ischemic stroke in an example rat.**(**a**) shows example qMRI images over a 4 h period of ischemia. The first four columns show D~av~ maps, qT~2~ maps, qT~1~ maps and T~2~ weighted images respectively. Remaining columns show the D~av~ maps with various representations of the automatically segmented lesions. The automatically detected D~av~ lesion is shown in column 5 in red. In column 6 the D~av~ lesion is shown in red with voxels with high qT~2~ shown in green. In column 7 the D~av~ lesion is shown in red with high qT~1~ voxels shown in green. In column 8 the D~av~ lesion is shown in red with voxels with both elevated qT~1~ and qT~2~ (V^overlap^) shown in green. (**b**) shows the distribution of qT~2~ in the D~av~ lesion as a function of time post MCAO, as well as the non-lesion qT~2~distribution at time zero. (**c**) shows the corresponding qT~1~ distributions, the adjacent legend pertaining to both panels (b) and (c). (**d**) shows a TTC-stained brain slice after the animal was sacrificed at 6 h post-MCAO. [Please click here to view a larger version of this figure.](http://ecsource.jove.com/files/ftp_upload/55277/55277fig1large.jpg)

**Figure 2: The relationships between time post-MCAO and qMRI parameters relevant to the timing of ischemia.** (**a**) shows f~1~, (**b**) the f~2~, (**c**), V^overlap^, (**d**),ΔT~1~and (**e**), ΔT~2~. Best fit for each parameter (solid red line) and RMSE bars (solid black lines) are shown. Dotted lines represent each of the indivudual 5 rats subjected to MCAO. [Please click here to view a larger version of this figure.](http://ecsource.jove.com/files/ftp_upload/55277/55277fig2large.jpg)

Discussion
==========

The current protocol for estimation of stroke onset time in rats uses quantitative diffusion and relaxation time MRI data rather than signal intensities of respective weighted MR contrast images[@B18]. Recent evidence points to inferior performance of image intensities in estimating stroke onset time [@B13][@B24]. In the \'diffusion-positive\' stroke lesion our MRI protocol provides stroke onset times from qT~1~ and qT~2~ MRI data with an accuracy of half an hour or so. It is a general trend that qT~2~ data outperforms that of qT~1~. The best accuracy for onset time determination is obtained from the volume of overlapping elevated qT~1~ and qT~2~(V^overlap^).

The images in [Figure 1](#F1){ref-type="fig"} demonstrate that while the reduced diffusion coefficient appears rather uniform, regions with abnormal qT~1~ and qT~2~ are heterogeneously scattered within the ischemic lesion. This finding is in accordance with previous observations and is likely due to different sensitivities of these qMRI parameters to pathophysiological changes caused by ischemia [@B5]. This suggests qMRI parameters may be informative of tissue status and supports notions that DWI over-estimates ischemic damage [@B25]. Indeed, recent preclinical evidence points toward the heterogeneity of ischemic damage within diffusion defined lesions [@B26]. Thus, the combination of diffusion, qT~1~ and qT~2~ potentially provides information on stroke onset time and tissue status, both of which are clinically useful for treatment decisions regarding patients with unknown onset.

V^overlap^ and f~2~ gave the most accurate estimates of stroke onset time. The benefit of quantifying relaxation times is that unlike signal intensities they are insensitive to inherent variations caused by technical factors such as magnetic field inhomogeneities and proton density [@B5], including the expected magnetic field variation within the ischemic lesion [@B17]. Reduced uncertainty associated with onset time estimates of qT~1~ and f~1~ are likely due to the aforementioned bi-phasic response of qT~1~ to ischemia, which contributes to the shallow slope of the time-dependent qT~1~ change [@B7][@B14][@B15]. The MRI data shown ([Figure 2](#F2){ref-type="fig"}) are in accordance with previous works [@B12][@B13], in that the time courses of relaxation time differences between the ischemic and contralateral non-ischemic brain are adequately described by linear functions. It is, however, important to note that the underpinning hydrodynamic changes due to ischemia are not linear [@B0][@B17].

The current MRI protocol for stroke time is demonstrated in rats subjected to permanent ischemia using the Longa et al. procedure [@B21]. In our experience, the Longa et al. procedure fails to induce MCAO in 10-20% of rats, however, as ADC is used to verify presence of ischemia, the experiments can be terminated prematurely. Failure to induce MCAO is often due to imperfect occluder thread. A further factor resulting in experimental failures is that MCAO is a severe procedure causing death of up to 20% of rats during a prolonged MRI session.

The stroke onset timing protocol applies only to permanent ischemia. In rat focal ischemia with reperfusion, the relationship between D~av~ and qT~1~ or qT~2~ will dissociate as D~av~ recovers, but may not for qT~1~ and qT~2~ depending on duration of ischemia prior to reperfusion [@B7][@B27]. Additionally, the evolution of ischemic damage is likely to be more variable in stroke patients due to individual differences in factors affecting microcirculation such as age and co-morbidities (*e.g.*, diabetes, hypertension, heart disease). These factors will inevitably influence the time dependence of f~1~, f~2~ and V^overlap^ in human strokes and thus requires investigation in clinical settings.

To conclude, qMRI parameters provide estimates of stroke onset time. V^overlap^ and f~2~ provide the most accurate estimates and may also be informative of tissue status. qMRI could therefore be clinically beneficial in terms of aiding treatment decisions for patients with unknown onset time. An issue to be considered here is that the gray-to-white-matter ratio in rat brain is much higher than in humans, and hydrodynamics in these brain tissue types may vary [@B17]. Nevertheless, further investigation into the time dependence of f~2~, V^overlap^ and qT~2~ in hyper acute stroke patients is warranted.
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